1. Home
  2. VHC vs ICCM Comparison

VHC vs ICCM Comparison

Compare VHC & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$16.20

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.68

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
ICCM
Founded
2005
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
43.4M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
VHC
ICCM
Price
$16.20
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
8.9K
175.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.17
N/A
EPS
N/A
N/A
Revenue
$5,000.00
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$31.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.60
$0.54
52 Week High
$29.00
$1.53

Technical Indicators

Market Signals
Indicator
VHC
ICCM
Relative Strength Index (RSI) 45.92 61.90
Support Level $15.94 $0.68
Resistance Level $18.09 $0.74
Average True Range (ATR) 1.50 0.04
MACD 0.15 0.01
Stochastic Oscillator 47.28 79.21

Price Performance

Historical Comparison
VHC
ICCM

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: